New Multiple Sclerosis Treatment Clinical Trial Begins Enrollment
Clinical trial of Autologous Hematopoietic Stem Cell Transplantation versus Best Available Therapy for Multiple Sclerosis (BEAT-MS) begins enrollment
Source: Disabled World - Category: Disability Tags: Clinical Trials Source Type: news
More News: Clinical Trials | Disability | Multiple Sclerosis | Stem Cell Therapy | Stem Cells | Transplants